SOLACI-CACI 2021 | Day 1: Main Arena Auditorium

✔️ Day 1, SOLACI-CACI 2021
✔️ Main Arena Auditorium

👨‍🏫 Program:

  • 06:20 – TCT@SOLACI-CACI 2021 Session – “The Future of PCI”
  • 01:33:19 – PCR@SOLACI-CACI 2021 Session
    👉 How to manage Coronary Artery Disease in patients with Severe Aortic Stenosis eligible for TAVI?
    👉 How to predict, how to avoid peri-procedural coronary obstruction during a TAVI procedure?
    👉 How to solve technical issues during PCI in a patient with a transcatheter heart valve previously implanted
  • 03:17:43 – Oral presentation – Structural I
  • 04:52:02 – Oral presentation – Coronary I
  • 06:14:52 – SCAI@SOLACI-CACI 2021 Session
  • 07:54:02 – Siemens Healthineers Symposium – “PCI image guidance and robotic automation for precise treatment”

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

SOLACI-CACI 2021 | Day 2: Main Arena Auditorium

✔️ Day 2, SOLACI-CACI 2021 ✔️ Main Arena Auditorium 👨‍🏫 Program: 00:01 - TCT@SOLACI-CACI 2021 Session: "Structural Heart Interventions" 01:30:26 - CRT@SOLACI-CACI 2021 Session 02:51:13 - Oral...

SOLACI-CACI 2021 | Day 3: Main Arena Auditorium

✔️ Day 3 Completo, SOLACI-CACI 2021 ✔️ Main Arena Auditorium 👨‍🏫 Program: 00:05 - CBS@SOLACI-CACI Session 01:43:26 - CCI@SOLACI-CACI Session 03:07:38 - Oral presentation – Structural III 04:32:21 -...

SOLACI-CACI 2021 | Day 4: Main Arena Auditorium

✔️ Day 4, SOLACI-CACI 2021 ✔️ Main Arena Auditorium 👨‍🏫 Program: 00:09 - The MIL Group/SOLACI/CACI/WAO Gender Opportunities in Interventional Cardiology 01:30:55 - Current and Immediate...

SOLACI-CACI 2021 | Day 5: Salón Main Arena

✔️ Day 5, SOLACI-CACI 2021 ✔️ Main Arena Auditorium 👨‍🏫 Program: 00:06 - DAPT Session 01:48:31 - Cardiovascular Disease Management and Cath Lab During the COVID-19...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Atrial Fibrillation After Percutaneous Patent Foramen Ovale Closure: Cohort Study with Continuous Implantable Cardiac Monitoring

Atrial fibrillation (AF) is a recognized complication following percutaneous closure of a patent foramen ovale (PFO), with reported incidences of up to 30% during...

Impact of Baseline Systolic Blood Pressure on Blood Pressure Changes Following Renal Denervation

Renal denervation (RDN) is a guideline-recommended therapy to reduce blood pressure in patients with uncontrolled hypertension, although uncertainties remain regarding which factors best predict...

AHA 2025 | OPTIMA-AF: 1 Month vs. 12 Months of Dual Therapy (DOAC + P2Y12) After PCI in Atrial Fibrillation

Concomitant atrial fibrillation (AF) and coronary artery disease is a common occurrence in clinical practice. In these patients, current guidelines recommend 1 month of...